← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 15, 2017Last known activity
Mar 1, 2026
Timeline
2010s
- Jun 1, 2015
NeuroRx, Inc.— Founded
Drugs by trial phase (7 distinct, 15 trials)
Phase 3 (7 own, 0 via acquisition)
Indications
Recent trials (23)
- NCT04453839Study chairN/A—
- NCT05779267Lead sponsorN/A—
- NCT04453839Lead sponsorN/A—
- NCT07227103Lead sponsorPhase 2/Phase 3Mar 1, 2026
- NCT06128213Lead sponsorPhase 2Mar 31, 2024
- NCT05137795Lead sponsorPhase 2/Phase 3Dec 15, 2021
- NCT04990466Lead sponsorPhase 2/Phase 3Sep 30, 2021
- NCT06729606CollaboratorPhase 3Apr 20, 2021
- NCT04843761CollaboratorPhase 3Apr 20, 2021
- NCT04360096Lead sponsorPhase 2/Phase 3Jun 1, 2020
- NCT04360096Study chairPhase 2/Phase 3Jun 1, 2020
- NCT04311697Study chairPhase 2Apr 30, 2020
- NCT04311697Lead sponsorPhase 2Apr 30, 2020
- NCT03396068Study directorPhase 2/Phase 3May 1, 2018
- NCT03396601Lead sponsorPhase 3May 1, 2018
Details
- Founded
- Wilmington, DE, US Jun 1, 2015
- Last known activity
- Mar 1, 2026